Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
Merck & Co Inc
(NYSE:MRK)
103.00
Delayed Data
As of Sep 29
-1.30
/
-1.25%
Today’s Change
86.02
Today
|||
52-Week Range
119.65
-7.17%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest MRK News
|
Press Releases
Merck (MRK) Dips More Than Broader Markets: What You Should Know
Sep 29 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: EU Nod to PFE's Litfulo, FDA Priority Tag to MRK Applications
Sep 22 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: FDA and EMA Regulatory Updates for ABBV, LLY, SNY & MRK's Drugs
Sep 29 / Zacks.com - Paid Partner Content
3 Reasons to Buy Merck Stock
Sep 22 / MotleyFool.com - Paid Partner Content
Bionomics (BNOX) Meets Goals in PTSD Study, Stock Rallies 244%
Sep 29 / Zacks.com - Paid Partner Content
Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?
Sep 22 / Zacks.com - Paid Partner Content
Ligand (LGND) Acquires Certain Assets of Novan for $12.2M
Sep 28 / Zacks.com - Paid Partner Content
Merck (MRK) Stock Moves -0.54%: What You Should Know
Sep 21 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights Alphabet, Exxon Mobil, Merck, Abbott Laboratories and NextEra Energy
Sep 28 / Zacks.com - Paid Partner Content
Merck (MRK) Keytruda Cervical Cancer sBLA Gets FDA Priority Tag
Sep 21 / Zacks.com - Paid Partner Content
Merck (MRK) Stock Sinks As Market Gains: What You Should Know
Sep 27 / Zacks.com - Paid Partner Content
Merck (MRK) Stock Moves -0.05%: What You Should Know
Sep 20 / Zacks.com - Paid Partner Content
Top Stock Reports for Alphabet, Exxon Mobil & Merck
Sep 27 / Zacks.com - Paid Partner Content
FDA Accepts Merck (MRK) sNDA for Welireg in Renal Cell Carcinoma
Sep 20 / Zacks.com - Paid Partner Content
Merck (MRK), Eisai Combo Therapy Fail Two Lung Cancer Studies
Sep 25 / Zacks.com - Paid Partner Content
Ligand (LGND) to Spin Out Pelican Subsidiary, Updates '23 View
Sep 19 / Zacks.com - Paid Partner Content
Seagen's (SGEN) Combo Drug Meets Goals in Bladder Cancer Study
Sep 25 / Zacks.com - Paid Partner Content
Why Shares of Iovance Biotherapeutics Jumped Monday
Sep 18 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights Pfizer, Merck and AstraZeneca
Sep 25 / Zacks.com - Paid Partner Content
Merck (MRK) Gets CHMP Nod for Keytruda in Adjuvant Lung Cancer
Sep 18 / Zacks.com - Paid Partner Content
Bristol Myers' (BMY) Opdivo Positive in Late-Stage NSCLC Study
Sep 22 / Zacks.com - Paid Partner Content